Bolt Biotherapeutics, Inc. Annual Operating Margin in % from 2020 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2024.
  • Bolt Biotherapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -950 %, a 1.81% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2024 was -950 %, a 1.81% increase from 2023.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2023 was -967 %, a 38.6% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2022 was -1.58K %, a 78.6% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -950 +17.5 +1.81% Jan 1, 2024 Dec 31, 2024
2023 -967 +609 +38.6% Jan 1, 2023 Dec 31, 2023
2022 -1.58K +5.79K +78.6% Jan 1, 2022 Dec 31, 2022
2021 -7.36K +13.9K +65.4% Jan 1, 2021 Dec 31, 2021
2020 -21.3K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.